Valisure is an American independent laboratory focused on the testing the purity and safety of pharmaceutical drugs and consumer products.[1] Valisure was founded in 2015 in New Haven.[1]

Valisure
Company typePrivate
Founded2015
Key people
David Light

History edit

Valisure was founded in 2015 by Adam Clark-Joseph and David Light.[2] After taking an anticonvulsant medication and experiencing negative side effects due to the poor quality of the drug, Clark-Joseph contacted Light about establishing a business testing pharmaceutical products.[2] Valisure was originally established as a pharmacy, which, unlike typical pharmacies, tested drugs before distributing them.[1] Valisure divested of the pharmacy business in 2021, opting instead to focus on testing.[1]

In 2019, Valisure reported that it had tested Zantac and generic equivalents and discovered that they contained N-Nitrosodimethylamine, which is thought to be a carcinogen.[3] In 2021, Johnson & Johnson recalled sun tan lotions after Valisure discovered they contained high levels of benzene.[3][4][5]

Clients of Valisure include Kaiser Permanente and the United States Armed Forces.[2][6]

References edit

  1. ^ a b c d Edney, Anna (9 November 2022). "A Tiny Lab Finds Danger on Drugstore Shelves While the FDA Lags Behind". Bloomberg.com. Retrieved 5 December 2023.
  2. ^ a b c Edney, Anna; Griffin, Riley (5 December 2023). "The Pentagon Wants to Root Out Shoddy Drugs. The FDA Is In Its Way". Bloomberg.com. Retrieved 5 December 2023.
  3. ^ a b Smyth, Jamie (4 September 2022). "US lab at the centre of legal fight over Zantac and cancer". The Financial Times. Retrieved 6 December 2023.
  4. ^ Erman, Michael; Steenhuysen, Julie (16 July 2021). "FDA investigating how a known carcinogen wound up in J&J sunscreen". Reuters.
  5. ^ Perkins, Tom (18 March 2022). "Carcinogenic chemical benzene found in hundreds of US personal care products". The Guardian. Retrieved 6 December 2023.
  6. ^ Griffin, Riley; Anna, Edney (16 August 2023). "Not All Generic Drugs Are Created Equal". Bloomberg.com. Retrieved 5 December 2023.